Melanocyte Growth Media-4

MGM-4 has been optimized for the growth and proliferation of normal human primary melanocytes in culture. This medium system has been shown to deliver superior results as compared to other existing commercial media systems. Melanocytes in culture maintain >90% functionality based on the conversion of L-dopa to dopa-melanin. The melanocyte media system also allows for normal morphology and proliferative capacity after recovery from cryopreservation and throughout serial passaging.

Adult melanocytes also require the addition of Et-3 (CC-4510), sold separately

Shelf Life:
6 months
Categories:
Primary Cells and Media
Research Areas:
Cancer Research/Cell Biology
Dermatology/Tissue Engineering

Citations

Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Tringali C, Silvestri I, Testa F, Baldassari P, Anastasia L, Mortarini R, Anichini A, López-Requena A, Tettamanti G, Venerando B 
In:
BMC Cancer (2014) 14: 560 
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Fernández-Barral A, Orgaz JL, Baquero P, Ali Z, Moreno A, Tiana M, Gómez V, Riveiro-Falkenbach E, Cañadas C, Zazo S, Bertolotto C, Davidson I, Rodríguez-Peralto JL, Palmero I, Rojo F, Jensen LD, del Peso L, Jiménez B. 
In:
Neoplasia (2014) 16(6): 529-42 
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Fernández-Barral A1, Orgaz JL, Gomez V, del Peso L, Calzada MJ, Jiménez B. 
In:
PLoS ONE (2012) 7(3): e32989 
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Lo Monaco E1, Tremante E, Cerboni C, Melucci E, Sibilio L, Zingoni A, Nicotra MR, Natali PG, Giacomini P. 
In:
Neoplasia (2011) 13(9): 822-30 
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Aguzzi MS1, Fortugno P, Giampietri C, Ragone G, Capogrossi MC, Facchiano A. 
In:
Mol Cancer (2010) 9: 84